Lucas GC Limited (LGCL)
NASDAQ: LGCL · Real-Time Price · USD
0.5233
-0.0357 (-6.39%)
At close: Aug 5, 2025, 4:00 PM
0.5235
+0.0002 (0.04%)
After-hours: Aug 5, 2025, 4:35 PM EDT

Sage Therapeutics Revenue

In the year 2024, Lucas GC had annual revenue of 1.06B CNY, down -27.85%. Lucas GC had revenue of 457.89M in the half year ending December 31, 2024, a decrease of -1.28%.

Revenue (ttm)
1.06B CNY
Revenue Growth
-27.85%
P/S Ratio
0.30
Revenue / Employee
3,333,571 CNY
Employees
319
Market Cap
58.38M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241.06B-410.55M-27.85%
Dec 31, 20231.47B707.39M92.28%
Dec 31, 2022766.57M114.33M17.53%
Dec 31, 2021652.25M422.04M183.33%
Dec 31, 2020230.21M182.12M378.73%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apple408.63B
Microsoft281.72B
NVIDIA148.52B
Taiwan Semiconductor Manufacturing Company116.30B
Oracle57.40B
Broadcom57.05B
Cisco Systems55.62B
SAP SE42.15B
Revenue Rankings